Phase-III Clinical and Bioequivalence Study to Evaluate Efficacy and safety of Antihyperparathyroidism and Antianginal D
Sábháilte in:
Príomhchruthaitheoir: | Choulwar Amol K. |
---|---|
Formáid: | LEABHAR |
Teanga: | Béarla |
Foilsithe / Cruthaithe: |
Mumbai
NMIMS-SPPSPTM
2013
|
Ábhair: | |
Clibeanna: |
Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|
Míreanna comhchosúla
Míreanna comhchosúla
-
BY USING DIFFERENT ANALYTICAL TECHNIQUES, ANALYSING THE DESIGNED DRUG RANOLAZINE -AN ANTIANGINAL DRUG
de réir: PRUTHA PATEL
Foilsithe / Cruthaithe: (2019) -
Advanced accounts volume 2
de réir: Shukla, M.
Foilsithe / Cruthaithe: (1997) -
Bioequivalence Studies to Evaluate Efficacy and Safty of Antiretroval and Antituberculosis Drug
de réir: Halde Supriya
Foilsithe / Cruthaithe: (2012) -
ISDN : D CHANNEL IN DIALOGUE
de réir: GOLLER, J
Foilsithe / Cruthaithe: (2000) -
Conductionof Clilical Phase in Bioavailability and Bioequivalence Study
de réir: Singh Abhishek Bijoy